No Data
Immix Biopharma to Present at the Stifel 2024 Cell Therapy Forum
LOS ANGELES, June 17, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. ("ImmixBio", "Company", "We" or "Us" or "IMMX"), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today
Immix Biopharma(IMMX.US) Officer Buys US$5,538 in Common Stock
$Immix Biopharma(IMMX.US)$ Officer Rachman Ilya M purchased 2,600 shares of common stock on Jun 7, 2024 at an average price of $2.13 for a total value of $5,538.Source: Announcement What is statement
Express News | RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
Immix Biopharma(IMMX.US) Officer Buys US$5,970.03 in Common Stock
$Immix Biopharma(IMMX.US)$ Officer Rachman Ilya M purchased 3,300 shares of common stock on Jun 4, 2024 at an average price of $1.8091 for a total value of $5,970.03.Source: Announcement What is state
Immix Biopharma(IMMX.US) Officer Buys US$5,972.67 in Common Stock
$Immix Biopharma(IMMX.US)$ Officer Morris Gabriel S purchased 3,300 shares of common stock on Jun 4, 2024 at an average price of $1.8099 for a total value of $5,972.67.Source: Announcement What is sta
Immix Biopharma Insiders Placed Bullish Bets Worth US$625.7k